Catalyst Wire Dossier Catalyst Wire Dossier

Stivarga

regorafenib · Bayer
Drug timelines are a Plus or Pro feature.

94 regulatory and trial events tracked for Stivarga, covering 2012-09-27 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Continued Treatment With Regorafenib in Participants With Solid Tumors Who Have Participated in Other Bayer Studies [Phase 2]

See pricing